In addition, we found a significant increase in Cxcl12 expression in CHOP-treated group but not in its receptor Cxcr4, being relevant, since the CXCL12–CXCR4 axis has been associated with tumor invasion and metastases (57). The gene discussed is CXCL12; the disease is neoplasm.